SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-022411
Filing Date
2020-05-07
Accepted
2020-05-07 08:52:50
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arpo-10q_20200331.htm 10-Q 1424509
2 EX-31.1 arpo-ex311_7.htm EX-31.1 20395
3 EX-31.2 arpo-ex312_9.htm EX-31.2 21633
4 EX-32.1 arpo-ex321_6.htm EX-32.1 10530
5 EX-32.2 arpo-ex322_8.htm EX-32.2 11769
  Complete submission text file 0001564590-20-022411.txt   4617165

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT arpo-20200331.xml EX-101.INS 905779
7 XBRL TAXONOMY EXTENSION SCHEMA arpo-20200331.xsd EX-101.SCH 35640
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arpo-20200331_cal.xml EX-101.CAL 29277
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arpo-20200331_def.xml EX-101.DEF 65000
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE arpo-20200331_lab.xml EX-101.LAB 279027
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arpo-20200331_pre.xml EX-101.PRE 199647
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 20854772
SIC: 2834 Pharmaceutical Preparations